Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function

Metastasis-associated protein 1 (MTA1) is widely overexpressed in human cancers and is associated with malignant phenotypic changes contributing to morbidity in the associated diseases. Here we discovered for the first time that MTA1, a master chromatin modifier, transcriptionally represses the expr...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 287; no. 33; pp. 27843 - 27850
Main Authors Reddy, Sirigiri Divijendra Natha, Pakala, Suresh B., Molli, Poonam R., Sahni, Neil, Karanam, Narasimha Kumar, Mudvari, Prakriti, Kumar, Rakesh
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 10.08.2012
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Metastasis-associated protein 1 (MTA1) is widely overexpressed in human cancers and is associated with malignant phenotypic changes contributing to morbidity in the associated diseases. Here we discovered for the first time that MTA1, a master chromatin modifier, transcriptionally represses the expression of phosphatase and tensin homolog (PTEN), a tumor suppressor gene, by recruiting class II histone deacetylase 4 (HDAC4) along with the transcription factor Yin-Yang 1 (YY1) onto the PTEN promoter. We also found evidence of an inverse correlation between the expression levels of MTA1 and PTEN in physiologically relevant breast cancer microarray datasets. We found that MTA1 up-regulation leads to a decreased expression of PTEN protein and stimulation of PI3K as well as phosphorylation of its signaling targets. Accordingly, selective down-regulation of MTA1 in breast cancer cells increases PTEN expression and inhibits stimulation of the PI3K/AKT signaling. Collectively, these findings provide a mechanistic role for MTA1 in transcriptional repression of PTEN, leading to modulation of the resulting signaling pathways. Background: MTA1 is overexpressed in several advanced cancers, but its role in cell survival signaling is yet to be elucidated. Results: MTA1 transcriptionally represses the expression of PTEN and, consequently, PTEN-dependent signaling and functions. Conclusion: PTEN is a target of the MTA1/HDAC4-containing NuRD complex. Significance: This study provides a novel mechanistic insight into the regulation of PTEN by MTA1.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey, NJ 08854.
ISSN:0021-9258
1083-351X
1083-351X
DOI:10.1074/jbc.M112.348474